Nasdaq?, page-61

First 61 Last

Share
Profile

Follow
Glyco

6,165 Posts.

2345

16/03/19

11:31

Post #: 37783552
Share

Originally posted by Ruby15: ↑

correction to my last post. It should have read MOU's, not IMO's.

GMV is hamstrung at the moment by the Chinese with regard to the uncertainty surrounding the approval of the Prizma Jacket & the Gmed Patch by the CFDA. In the event that GMV has to postpone the listing on the Nasdaq for a possible six mths, it would allow the following contracts to be raised:

Purchase Order from Zingmobile for the Prizma Jacket valued at 3 million,
Shandong Boletong MOU signed for 67.5 million,
USA Medtel signed MOU for 10.5 million,
MOU signed with Greece & Cyprus for 10.5 million,
MOU signed with India & Taiwan for 405 million, and
Silverlake has agreed to purchase upto 4,050,000 Prizma Jackets.

Obviously the above contracts are contigent on GMV securing the CFDA Approval. I'm slightly bemused as to why the CFDA Approval is drawing out as long as it has and I say this because the factory was approved back in Oct. Why haven't the OTC approvals been granted???. This is why the loyal LTH's are so frustrated and we have every reason to.

Not only are the faithful SH's frustrated but this also goes for Dr G and his team. What is comforting, is the fantastic team that Dr G has surrounded himself with and only this month, he has secured the services of Dr Rotstein a world renowned and respected Cardiologist.

As I have stated on numerous occassions, GMV would have to be the most undervalued Stock on the ASX. They have a fully integrated device with 24/7 remore monitoring backed up with a cloud platform. Its key advantages are for the use of both the Prizma Jacket and Gmed Patch in hospitals, at home, for emergency services and nursing homes. GMV has the product to truly revolutionise the health system.

Stay positive and demonstrate patience and all our dreams will come through.

Go GMV.

Cheers Rubes

Expand

Ruby15
Like to make a correction to yr post:

They can sell Primzas in non-china regions (*Zingmobile/SEAsia, EU, Usa, Taiwan, India if FCL is sorted),
but not in china ( BSilverlake & SBoletong) until we get cfda.

Deals outside of china are Big & sufficient to take us to Nasdaq/ADR with change to spare.
aimo

Last edited by Glyco: 16/03/19

GMV Price at posting: 28.5¢ Sentiment: Buy Disclosure: Held
17 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 92 more messages in this thread...

First 61 Last

Add GMV (ASX) to my watchlist

Nasdaq?, page-61

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News